Literature DB >> 34289273

SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.

Garth Rapeport1, Emma Smith1, Anthony Gilbert1, Andrew Catchpole1, Helen McShane1, Christopher Chiu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34289273     DOI： 10.1056/NEJMp2106970

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

2.  Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2022-05-20       Impact factor: 5.926

3.  Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

Authors:  Ben Killingley; Alex J Mann; Mariya Kalinova; Alison Boyers; Niluka Goonawardane; Jie Zhou; Kate Lindsell; Samanjit S Hare; Jonathan Brown; Rebecca Frise; Emma Smith; Claire Hopkins; Nicolas Noulin; Brandon Löndt; Tom Wilkinson; Stephen Harden; Helen McShane; Mark Baillet; Anthony Gilbert; Michael Jacobs; Christine Charman; Priya Mande; Jonathan S Nguyen-Van-Tam; Malcolm G Semple; Robert C Read; Neil M Ferguson; Peter J Openshaw; Garth Rapeport; Wendy S Barclay; Andrew P Catchpole; Christopher Chiu
Journal:  Nat Med       Date:  2022-03-31       Impact factor: 87.241

4.  A comparison with historical influenza prompts better planning for Covid-19 and future pandemics, and gives grounds for optimism.

Authors:  Philip Mortimer
Journal:  Rev Med Virol       Date:  2021-10-29       Impact factor: 11.043

Review 5.  COVID-19 and antimicrobial resistance: A cross-study.

Authors:  Sidra Ghazali Rizvi; Shaikh Ziauddin Ahammad
Journal:  Sci Total Environ       Date:  2021-10-08       Impact factor: 7.963

6.  A Method for Intelligent Allocation of Diagnostic Testing by Leveraging Data from Commercial Wearable Devices: A Case Study on COVID-19.

Authors:  Jessilyn Dunn; Md Mobashir Hasan Shandhi; Peter Cho; Ali Roghanizad; Karnika Singh; Will Wang; Oana Enache; Amanda Stern; Rami Sbahi; Bilge Tatar; Sean Fiscus; Qi Xuan Khoo; Yvonne Kuo; Xiao Lu; Joseph Hsieh; Alena Kalodzitsa; Amir Bahmani; Arash Alavi; Utsab Ray; Michael Snyder; Geoffrey Ginsburg; Dana Pasquale; Christopher Woods; Ryan Shaw
Journal:  Res Sq       Date:  2022-04-01

7.  Human infection studies: Key considerations for challenge agent development and production.

Authors:  Shobana Balasingam; Sarah Meillon; Cecilia Chui; Alex Mann; Carine La; Charlotte L Weller; Deborah F King; Emma Smith
Journal:  Wellcome Open Res       Date:  2022-04-22

8.  Risk, benefit, and social value in Covid-19 human challenge studies: pandemic decision making in historical context.

Authors:  Mabel Rosenheck
Journal:  Monash Bioeth Rev       Date:  2022-06-15

Review 9.  Correlates of protection against SARS-CoV-2 infection and COVID-19 disease.

Authors:  David Goldblatt; Galit Alter; Shane Crotty; Stanley A Plotkin
Journal:  Immunol Rev       Date:  2022-06-05       Impact factor: 10.983

10.  Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission.

Authors:  David A Swan; Ashish Goyal; Chloe Bracis; Mia Moore; Elizabeth Krantz; Elizabeth Brown; Fabian Cardozo-Ojeda; Daniel B Reeves; Fei Gao; Peter B Gilbert; Lawrence Corey; Myron S Cohen; Holly Janes; Dobromir Dimitrov; Joshua T Schiffer
Journal:  Viruses       Date:  2021-09-24       Impact factor: 5.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.